Top Markets
#1 ADO Protocol ADO Protocol +335.42%
#2 GoPlus Security GoPlus Security +41.13%
#3 Starpower Starpower +35.26%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.65%
#6 The Black Bull The Black Bull +15.87%
#7 Nockchain Nockchain +14.43%
#8 Provenance Blockchain Provenance Blockchain +12.81%
#9 Casper Network Casper Network +12.45%
#10 DMT-NAT DMT-NAT +11.83%
Coin of the day
ADO Protocol ADO Protocol
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
Pozycja w akcjach #33275
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
Cena akcji
$5.39
Kapitalizacja rynkowa
$7.87M
Zmiana (1 dzień)
-2.45%
Zmiana (1 rok)
5.80%
Kraj
US
Handel CNS Pharmaceuticals, Inc. (CNSP)

Kategoria

Healthcare
Historia ceny akcji dla CNS Pharmaceuticals, Inc. (CNSP)
Najwyższa cena zamknięcia: $5.27 dnia 2026-08-01

Najniższa cena zamknięcia: $3.79M dnia 2019-11-01
Historia cen akcji firmy CNS Pharmaceuticals, Inc. od 2019 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -16.53%
2025 -89.84%
2024 -99.87%
2023 -34.43%
2022 -90.86%
2021 -58.90%
2020 -43.49%
2019 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $508.64 29.49%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $973.48 48.89%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $733.78 6.78%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $254.79 13.07%
BE